Skip to Main Content

Author Details

Yongwei Yu
Changhai Hospital
2001
68
25
PMIDPaper TitleJournal TitlePublished Year
36776524Gankyrin-mediated interaction between cancer cells and tumor-associated macrophages facilitates prostate cancer progression and androgen deprivation therapy resistance.Oncoimmunology2023
37202190[Berberine inhibits autophagy and promotes apoptosis of fibroblast-like synovial cells from rheumatoid arthritis patients through the ROS/mTOR signaling pathway].Nan Fang Yi Ke Da Xue Xue Bao2023
36644951Overexpression of YTHDC2 contributes to the progression of prostate cancer and predicts poor outcomes in patients with prostate cancer.J Biochem Mol Toxicol2023
3548586018 F-FDG and 68 Ga-FAPI-04 in the Evaluation of Aggressive Perivascular Epithelioid Cell Tumor.Clin Nucl Med2022
35793110Extended Focal Ablation of Localized Prostate Cancer With High-Frequency Irreversible Electroporation: A Nonrandomized Controlled Trial.JAMA Surg2022
33414463KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer.Cell Death Dis2021
33710368Combining UBR5 and CD163<sup>+</sup> tumor-associated macrophages better predicts prognosis of clear cell renal cell carcinoma patients.Cancer Immunol Immunother2021
33815409<i>TSPAN1, TMPRSS4, SDR16C5</i>, and <i>CTSE</i> as Novel Panel for Pancreatic Cancer: A Bioinformatics Analysis and Experiments Validation.Front Immunol2021
34348693Integrating HECW1 expression into the clinical indicators exhibits high accuracy in assessing the prognosis of patients with clear cell renal cell carcinoma.BMC Cancer2021
33420488Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression.Nat Cell Biol2021
32293722Clinical outcomes of 168 Chinese patients after local surgery for bone metastases arising from advanced renal cell carcinoma.Cancer2020
31957836Effects of lncRNA SNHG20 on proliferation and apoptosis of non-small cell lung cancer cells through Wnt/β-catenin signaling pathway.Eur Rev Med Pharmacol Sci2020
32655718FASN Protein Overexpression Indicates Poor Biochemical Recurrence-Free Survival in Prostate Cancer.Dis Markers2020
32706069CircRNA_010763 promotes growth and invasion of lung cancer through serving as a molecular sponge of miR-715 to induce c-Myc expression.Eur Rev Med Pharmacol Sci2020
32238934A genomic and epigenomic atlas of prostate cancer in Asian populations.Nature2020
32167077MAGI-2 downregulation: a potential predictor of tumor progression and early recurrence in Han Chinese patients with prostate cancer.Asian J Androl2020
30693666The preoperative neutrophil-to-lymphocyte ratio is not a marker of prostate cancer characteristics but is an independent predictor of biochemical recurrence in patients receiving radical prostatectomy.Cancer Med2019
28927585Whole-genome and Transcriptome Sequencing of Prostate Cancer Identify New Genetic Alterations Driving Disease Progression.Eur Urol2018
30235778Score for lung adenocarcinoma in China with EGFR mutation of exon 19: Combination of clinical and radiological characteristics analysis.Medicine (Baltimore)2018
29357946Follistatin-like protein 1 plays a tumor suppressor role in clear-cell renal cell carcinoma.Chin J Cancer2018
29662167Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.Nat Genet2018
28529626Cancer-derived Circulating MicroRNAs Promote Tumor Angiogenesis by Entering Dendritic Cells to Degrade Highly Complementary MicroRNAs.Theranostics2017
28336963Radiological and Clinical Features associated with Epidermal Growth Factor Receptor Mutation Status of Exon 19 and 21 in Lung Adenocarcinoma.Sci Rep2017
28945760Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data.PLoS Genet2017
28600503Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma.Sci Rep2017
26900347MicroRNA-410-5p as a potential serum biomarker for the diagnosis of prostate cancer.Cancer Cell Int2016
26556874Periostin expression in intra-tumoral stromal cells is prognostic and predictive for colorectal carcinoma via creating a cancer-supportive niche.Oncotarget2016
27588475NKAIN2 functions as a novel tumor suppressor in prostate cancer.Oncotarget2016
27815922Erratum to: TMPRSS2:ERG fusion gene occurs less frequently in Chinese patients with prostate cancer.Tumour Biol2016
27225192A genetic polymorphism affects the risk and prognosis of renal cell carcinoma: association with follistatin-like protein 1 expression.Sci Rep2016
27320318TMPRSS2:ERG fusion gene occurs less frequently in Chinese patients with prostate cancer.Tumour Biol2016
26881390A genetic study and meta-analysis of the genetic predisposition of prostate cancer in a Chinese population.Oncotarget2016
25934296Nonsense and missense mutation of mitochondrial ND6 gene promotes cell migration and invasion in human lung adenocarcinoma.BMC Cancer2015
24173294Gene expression profiling-derived immunohistochemistry signature with high prognostic value in colorectal carcinoma.Gut2014
25256860Environmental and psycho-social factors related to prostate cancer risk in the Chinese population: a case-control study.Biomed Environ Sci2014
24915821[Primary cardiac osteosarcoma: report of a case].Zhonghua Bing Li Xue Za Zhi2014
24704988A new tool for distinguishing muscle invasive and non-muscle invasive bladder cancer: the initial application of flexible ultrasound bronchoscope in bladder tumor staging.PLoS One2014
24243035miR-663 induces castration-resistant prostate cancer transformation and predicts clinical recurrence.J Cell Physiol2014
23442546Establishment and characterization of clear cell renal cell carcinoma cell lines with different metastatic potential from Chinese patients.Cancer Cell Int2013
24312560RhoC interacts with integrin α5β1 and enhances its trafficking in migrating pancreatic carcinoma cells.PLoS One2013
24137339A GWAS-identified susceptibility locus on chromosome 11q13.3 and its putative molecular target for prediction of postoperative prognosis of human renal cell carcinoma.Oncol Lett2013
24157827Genetic variation in the GSTM3 promoter confer risk and prognosis of renal cell carcinoma by reducing gene expression.Br J Cancer2013
23821160Expression of orphan nuclear receptor NR4A2 in gastric cancer cells confers chemoresistance and predicts an unfavorable postoperative survival of gastric cancer patients with chemotherapy.Cancer2013
23949154Effects of platelet-activating factor and its differential regulation by androgens and steroid hormones in prostate cancers.Br J Cancer2013
23609189The prostate cancer-up-regulated Myc-associated zinc-finger protein (MAZ) modulates proliferation and metastasis through reciprocal regulation of androgen receptor.Med Oncol2013
23652996Dishevelled-2 silencing reduces androgen-dependent prostate tumor cell proliferation and migration and expression of Wnt-3a and matrix metalloproteinases.Mol Biol Rep2013
23809767Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy.Eur J Cancer2013
21538163Diazoxide inhibits aortic endothelial cell apoptosis in diabetic rats via activation of ERK.Acta Diabetol2012
23231703Neural protein gamma-synuclein interacting with androgen receptor promotes human prostate cancer progression.BMC Cancer2012
22422151Oncogenic CUL4A determines the response to thalidomide treatment in prostate cancer.J Mol Med (Berl)2012
  • 1 - 50 of 68

Recommended Authors

Jiayu Liang
institute of urology
Career Start Year 2016
Number of shared co-authors 1
Yaser Gamallat
Cumming School of Medicine, University of Calgary
Career Start Year 2016
Number of shared co-authors 1
Yunyun Zhou
Children's Hospital of Philadelphia
Career Start Year 2015
Number of shared co-authors 1
Jongmin Sim
Korea University Anam Hospital, Korea University College of Medicine
Career Start Year 2012
Number of shared co-authors 0
Zhixin Qiu
UPMC Hillman Cancer Center
Career Start Year 2012
Number of shared co-authors 0
Zitong Zhao
School of Pharmacy, Wannan Medical College
Career Start Year 2012
Number of shared co-authors 4
Shingo Sakashita
National Cancer Center Exploratory Oncology Research & Clinical Trial Center
Career Start Year 2008
Number of shared co-authors 1
Kris Ylaya
Center for Cancer Research, National Cancer Institute
Career Start Year 2008
Number of shared co-authors 0
Liang Liang
Tangdu Hospital, Fourth Military Medical University
Career Start Year 2006
Number of shared co-authors 0
Hui Xue
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Career Start Year 2005
Number of shared co-authors 12
Esther Herpel
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 0
Fan Zhang
Huaihe Hospital of Henan University
Career Start Year 2004
Number of shared co-authors 8
Yongmei Song
Shandong University of Traditional Chinese Medicine
Career Start Year 2003
Number of shared co-authors 4
Xin Yang
Peking University Cancer Hospital & Institute
Career Start Year 2002
Number of shared co-authors 2
Limei Hu
Aier Eye Hospital of Wuhan University
Career Start Year 2001
Number of shared co-authors 2
Wei Zhang
Children's Hospital, Zhejiang University School of Medicine
Career Start Year 2001
Number of shared co-authors 1
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 1
Ni Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1997
Number of shared co-authors 1
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
Dong Lin
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Career Start Year 1996
Number of shared co-authors 13
Ronald Simon
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1996
Number of shared co-authors 4
Sang Yong Song
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Career Start Year 1995
Number of shared co-authors 0
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 0
Hidewaki Nakagawa
RIKEN Center for Integrative Medical Sciences
Career Start Year 1994
Number of shared co-authors 25
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 0
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 8
Holger Moch
University Hospital Zurich
Career Start Year 1991
Number of shared co-authors 8
Enhua Wang
The First Hospital and College of Basic Medical Sciences, China Medical University
Career Start Year 1990
Number of shared co-authors 1
Silvano Bosari
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1986
Number of shared co-authors 0
Hoguen Kim
Korea Advanced Institute of Science and Technology (KAIST)
Career Start Year 1982
Number of shared co-authors 0

Collaborators

Hongwei Zhang
General Hospital of Tibet Area Military Command
Co-authored papers 13
Yong-Jie Lu
Barts Cancer Institute, Queen Mary University of London
Co-authored papers 9
Fubo Wang
Center for Genomic and Personalized Medicine, Guangxi Medical University
Co-authored papers 7
Daniel M Berney
Barts Cancer Institute, Queen Mary University of London
Co-authored papers 6
Shancheng Ren
Shanghai Changzheng Hospital
Co-authored papers 6
Zsofia Kote-Jarai
The Institute of Cancer Research
Co-authored papers 3
Rosalind A Eeles
The Institute of Cancer Research
Co-authored papers 3
Liyan Xue
Xuzhou Central Hospital
Co-authored papers 3
David E Neal
University of Oxford, John Radcliffe Hospital
Co-authored papers 3
Barbara Kremeyer
University College London
Co-authored papers 2
Vincent J Gnanapragasam
University of Cambridge
Co-authored papers 2
Adam Butler
Wellcome Sanger Institute
Co-authored papers 2
Jorge Zamora
Universidade de Santiago de Compostela
Co-authored papers 2
Adam Lambert
University of Oxford
Co-authored papers 2
Nening Dennis
Institute of Cancer Research
Co-authored papers 2
Sandra Edwards
The Institute of Cancer Research
Co-authored papers 2
Song Wu
The Third Affiliated Hospital of Shenzhen University (Luohu Hospital Group)
Co-authored papers 2
Niedzica Camacho
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Charlie E Massie
University of Cambridge
Co-authored papers 2
Yasheng Zhu
Changhai Hospital, Naval Military Medical University
Co-authored papers 2
Ultan McDermott
Wellcome Sanger Institute
Co-authored papers 2
Keiran Raine
Wellcome Sanger Institute
Co-authored papers 2
Pelvender Gill
University of Oxford
Co-authored papers 2
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
David Jones
Wellcome Sanger Institute
Co-authored papers 2
Alan Thompson
The Royal Marsden NHS Foundation Trust
Co-authored papers 2
Hayley C Whitaker
University College London
Co-authored papers 2
George Steven Bova
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Co-authored papers 2
Luke Marsden
University of Oxford
Co-authored papers 2
Hayley J Luxton
University College London
Co-authored papers 2
Release 1.2